HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jeevanandam, V. Articles by Rose, E. A. Search for Related Content PubMed PubMed Citation Articles by Jeevanandam, V. Articles by Rose, E. A.

The Annals of Thoracic Surgery, Vol 52, 1213-1216, Copyright © 1991 by The Society of Thoracic Surgeons

ARTICLES

University of Wisconsin solution for human donor heart preservation: initial clinical experience

V Jeevanandam, ML Barr, JS Auteri, JA Sanchez, GY Ott, FA Schenkel, C Marboe, CR Smith and EA Rose
Department of Surgery, Columbia-Presbyterian Medical Center, New York, New York 10032.

Although in vitro and primate orthotopic transplant experiments have suggested the superiority of University of Wisconsin solution (UWS) compared with crystalloid cardioplegia and saline solution storage for hypothermic heart preservation, concerns about the viscosity and the high potassium concentration of UWS have precluded its use in human cardiac transplantation. To test the safety and efficacy of UWS, 16 patients received hearts arrested with, flushed with, and stored in UWS at 4 degrees C for a mean ischemic time of 153.3 +/- 30.7 minutes. After reperfusion, the hearts contracted vigorously and attained a stable sinus rhythm within 4.0 +/- 2.4 minutes, and the patients were weaned from bypass in 24.5 +/- 8.0 minutes. There was no evidence of acute or chronic ischemic myocardial injury by enzymatic analysis, electrocardiography, or biopsy specimen histology. The results suggest UWS can be safely used, within currently accepted limits of donor ischemic time, to arrest and preserve human hearts for transplantation. Further studies of preservation are required to compare UWS with crystalloid cardioplegia and saline solution storage and to test the ability of UWS to prolong the period of safe donor hypothermic ischemia in clinical heart transplantation.

This article has been cited by other articles:

				J. P. Slater, M. M.R. Amirhamzeh, O. J. Yano, A. S. Shah, J. P. Starr, R. J. Kaplon, W. Burfeind, P. Pepino, R. E. Michler, E. A. Rose, et al. Discriminating Between Preservation and Reperfusion Injury in Human Cardiac Allografts Using Heart Weight and Left Ventricular Mass Circulation, November 1, 1995; 92(9): 223 - 227. [Abstract] [Full Text]

				J. M. Pearl, H. Laks, D. C. Drinkwater, T. J. Sorensen, P. Chang, A. S. Aharon, R. E. Byrns, and L. J. Ignarro Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 257 - 264. [Abstract] [Full Text]